MAIA Biotechnology (MAIA) announced that it has entered into a clinical supply agreement with BeiGene (BGNE) to assess the efficacy of THIO, its small molecule telomere-targeting anticancer agent ...
Along with a third ODD in glioblastoma, the FDA has clearly recognized THIO’s potential as an effective treatment for multiple cancer indications. Comparatively, most oncology compounds at this ...
The researchers refer to these new lipids as Thio-lipids. The collaboration demonstrated ... senior research associate at OSU Lipids are organic compounds containing fatty tails and are found ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback